Publication | Closed Access

Tocilizumab masks the clinical symptoms of systemic juvenile idiopathic arthritis-associated macrophage activation syndrome: The diagnostic significance of interleukin-18 and interleukin-6

InflammationRheumatologyClinical SymptomsAutoimmune DiseaseImmunologyPathologyAutoimmunityPaediatric RheumatologyDiagnostic SignificanceInflammatory Rheumatic DiseaseImmunologic DiseaseMedicineRheumatoid ArthritisSystemic Juvenile Idiopathic Arthritis